DIVA Laboratories Ltd (4153) — Cash Flow Reinvestment Rate
DIVA Laboratories Ltd (4153) has a Cash Flow Reinvestment Rate of 0.04x as of December 2025, reinvesting NT$241.00K (capex NT$241.00K ) from operating cash flow of NT$5.57 Million. Explore 4153 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DIVA Laboratories Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for DIVA Laboratories Ltd across 7 annual periods. Also explore DIVA Laboratories Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for DIVA Laboratories Ltd (2017–2025)
Year-by-year capital reinvestment analysis for DIVA Laboratories Ltd. For live market cap and broader valuation context, see 4153 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | NT$1.00 Million | NT$20.77 Million | NT$1.00 Million | ▲ +178.2% |
| 2024 | 0.02x | NT$2.13 Million | NT$123.14 Million | NT$2.13 Million | ▼ -43.1% |
| 2023 | 0.03x | NT$7.69 Million | NT$252.91 Million | NT$7.69 Million | ▼ -86.5% |
| 2022 | 0.22x | NT$16.46 Million | NT$73.19 Million | NT$11.42 Million | ▼ -83.4% |
| 2019 | 1.35x | NT$71.34 Million | NT$52.66 Million | NT$12.79 Million | ▲ +403.6% |
| 2018 | 0.27x | NT$23.14 Million | NT$86.02 Million | NT$21.71 Million | ▼ -81.8% |
| 2017 | 1.48x | NT$61.14 Million | NT$41.45 Million | NT$13.31 Million | — |